Edition:
United States

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

5.30USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$5.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,460
52-wk High
$6.68
52-wk Low
$4.41

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.05 0.10 0.03 0.03
Quarter Ending Mar-19 3 0.05 0.10 0.03 --
Year Ending Dec-18 3 0.48 0.50 0.46 13.19
Year Ending Dec-19 3 0.18 0.30 0.12 5.14
Earnings (per share)
Quarter Ending Dec-18 3 -0.19 -0.18 -0.20 -0.22
Quarter Ending Mar-19 3 -0.17 -0.10 -0.22 --
Year Ending Dec-18 3 -0.77 -0.76 -0.78 -0.55
Year Ending Dec-19 3 -0.81 -0.64 -0.90 -0.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.35 29.37
P/E High - Last 5 Yrs. -- 265.82 45.81
P/E Low - Last 5 Yrs. -- 84.07 25.31
Beta -- 0.73 0.91
Price to Sales (TTM) -- 217.47 20.58
Price to Book (MRQ) -- 16.39 4.23
Price to Tangible Book (MRQ) -- 20.75 12.86
Price to Cash Flow (TTM) -- 48.37 21.21
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 147.93 6.76
Sales (TTM) vs TTM 1 Yr. Ago -- 61.15 5.37
Sales - 5 Yr. Growth Rate -- 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 79.13 28.02
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 20.46 7.61
Capital Spending - 5 Yr. Growth Rate -- 34.49 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.61
Current Ratio (MRQ) -- 6.52 3.62
LT Debt to Equity (MRQ) -- 18.23 9.93
Total Debt to Equity (MRQ) -- 24.16 13.84
Interest Coverage (TTM) -- -167.44 35.68

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.55 52.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -157.69 16.18
Operating Margin (TTM) -- -1,764.78 -12.21
Operating Margin - 5 Yr. Avg. -- -170.84 11.72
Pre-Tax Margin (TTM) -- -1,697.48 -10.76
Pre-Tax Margin - 5 Yr. Avg. -- -173.51 12.02
Net Profit Margin (TTM) -- -1,693.34 -14.16
Net Profit Margin - 5 Yr. Avg. -- -173.87 8.28
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.71 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,450,900 843,863,939
Net Income/Employee (TTM) -- -3,607,100 98,307,273
Receivable Turnover (TTM) -- 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) -- 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.73 10.84
Return on Assets - 5 Yr. Avg. -- 2.39 11.60
Return on Investment (TTM) -- -0.31 13.58
Return on Investment - 5 Yr. Avg. -- 2.30 14.86
Return on Equity (TTM) -- -2.99 15.11
Return on Equity - 5 Yr. Avg. -- -1.52 16.02

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.